News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in 1st line EGFRm NSCLC
Noemi Reguart/X
Mar 26, 2025, 13:32

Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in 1st line EGFRm NSCLC

Noemi Reguart, Medical Oncologist at Hospital Clinic Barcelona, shared a post on X:

“Osimertinib BEATEN!!

MARIPOSA (Ami + Lazer) shows significant OS (HR 0.75, p<0.005, 3yr 60% vs 51%) and landmark 3-yr icPFS improvement (36% vs 18%)—first combo to show OS superiority over SoC, extending OS beyond 3 years in first line EGFRm NSCLC.”

Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in 1st line EGFRm NSCLC

cancer fight against cancer Global fight against cancer Hospital Clinic Barcelona MARIPOSA MedOnc Noemi Reguart NSCLC OncoDaily Oncology osimertinib
Special Coverage
Blog
Apr 18, 2025, 15:03
The Max Foundation - Thank you to everyone who attended 2025 Maximize Life Gala
Blog
Apr 18, 2025, 14:55
Sylvester Comprehensive Cancer Center is expanding access to world-class cancer care in Broward County
Opinion
Apr 18, 2025, 14:42
Berta Marti Fuster: That’s a wrap on the 2025 Analog Devices' General Technical Conference
Blog
Apr 18, 2025, 14:29
Antonio Giordano: Rep. Jesse Topper visited Sbarro Health Research Organization Genetic Research Laboratory
Blog
Apr 18, 2025, 14:07
Humaid Al-Shamsi: BCI signed an MoU with the European Institute of Oncology at Abu Dhabi Global Health Week
Blog
Apr 18, 2025, 13:54
Tanja Obradovic: Novel cell therapy is entering clinical development space
Drugs
Apr 18, 2025, 13:39
Amol Akhade: First-line treatment options for NSCLC with uncommon EGFR mutations
Blog
Apr 18, 2025, 13:07
Tanja Obradovic: Even rougher times ahead for Biotech?
Blog
Apr 18, 2025, 12:54
Adam Fein: New on Drug Channels - who really controls specialty drug dispensing?
Societies
Apr 18, 2025, 12:24
Giving Week 2025: There’s still time to activate or renew your ACS CAN membership
Positive
Apr 18, 2025, 12:14
2025 ASCO Annual Meeting Merit Award and Special Merit Award recipients
Insight
Apr 18, 2025, 11:51
Applications for 2025 Home Away From Home program are now open - Foundation S